StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) stock

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)

Close on Nov 16, 2026Market cap $1.52BP/E –Yield –

GeneDx total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

GeneDx's total debt was $96.84M at Jun 30, 2026. For fiscal 2025 it was $52.72M, down 0.8% from the year before. The highest annual figure on record is $53.19M in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$52.72M-0.8%
FY2024Dec 31, 2024$53.12M-0.1%
FY2023Dec 31, 2023$53.19M+383.5%
FY2022Dec 31, 2022$11.00M0.0%
FY2021Dec 31, 2021$11.00M-47.0%
FY2020Dec 31, 2020$20.74M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$96.84M+83.0%
Q1 FY2026Mar 31, 2026$96.73M+82.5%
Q4 FY2025Dec 31, 2025$52.72M-0.8%
Q3 FY2025Sep 30, 2025$52.81M-0.8%
Q2 FY2025Jun 30, 2025$52.91M-0.7%
Q1 FY2025Mar 31, 2025$53.01M-0.2%
Q4 FY2024Dec 31, 2024$53.12M-0.1%
Q3 FY2024Sep 30, 2024$53.24M+751.8%
Q2 FY2024Jun 30, 2024$53.26M+752.2%
Q1 FY2024Mar 31, 2024$53.09M+749.5%
Q4 FY2023Dec 31, 2023$53.19M+383.5%
Q3 FY2023Sep 30, 2023$6.25M-43.2%
Q2 FY2023Jun 30, 2023$6.25M-43.2%
Q1 FY2023Mar 31, 2023$6.25M-43.2%
Q4 FY2022Dec 31, 2022$11.00M0.0%
Q3 FY2022Sep 30, 2022$11.00M0.0%
Q2 FY2022Jun 30, 2022$11.00M-39.0%
Q1 FY2022Mar 31, 2022$11.00M-40.5%
Q4 FY2021Dec 31, 2021$11.00M-47.0%
Q3 FY2021Sep 30, 2021$11.00M–
Q2 FY2021Jun 30, 2021$18.03M–
Q1 FY2021Mar 31, 2021$18.50M–
Q4 FY2020Dec 31, 2020$20.74M–

More GeneDx figures

See a number that looks wrong?